Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population
In: Blood, Jg. 141 (2023-05-18), Heft 20, S. 2493-2507
Online
serialPeriodical
Zugriff:
•DHITsig expression extends beyond HGBCL-DH-BCL2to identify dark zone lymphomas and was thus renamed the “DZsig.”•DZsig refines cell-of-origin classification by identifying patients within GCB-DLBCL with inferior outcomes and shorter time to treatment.
Titel: |
Molecular determinants of clinical outcomes in a real-world diffuse large B-cell lymphoma population
|
---|---|
Autor/in / Beteiligte Person: | Alduaij, Waleed ; Collinge, Brett ; Ben-Neriah, Susana ; Jiang, Aixiang ; Hilton, Laura K. ; Boyle, Merrill ; Meissner, Barbara ; Chong, Lauren ; Miyata-Takata, Tomoko ; Slack, Graham W. ; Farinha, Pedro ; Craig, Jeffrey W. ; Lytle, Andrew ; Savage, Kerry J. ; Villa, Diego ; Gerrie, Alina S. ; Freeman, Ciara L. ; Gascoyne, Randy D. ; Connors, Joseph M. ; Morin, Ryan D. ; Sehn, Laurie H. ; Mungall, Andrew J. ; Steidl, Christian ; Scott, David W. |
Link: | |
Zeitschrift: | Blood, Jg. 141 (2023-05-18), Heft 20, S. 2493-2507 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 0006-4971 (print) ; 1528-0020 (print) |
DOI: | 10.1182/blood.2022018248 |
Sonstiges: |
|